Eli Lilly (LLY) Net Equity Issued and Repurchased (2012 - 2026)
Eli Lilly's Net Equity Issued and Repurchased came in at -$377 million for Q3 2026, compared with -$708 million a year earlier.
Powered by 
Analysis
Eli Lilly (LLY) Net Equity Issued and Repurchased (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Eli Lilly reported Net Equity Issued and Repurchased of -$5.84 billion; for FY2025, it came in at -$4.11 billion.
- Going back by year, Net Equity Issued and Repurchased was -$2.5 billion in FY2024, -$750 million in FY2023, -$1.5 billion in FY2022 and -$1.25 billion in FY2021.
- The Q3 2026 figure represents the highest quarterly Net Equity Issued and Repurchased since Q4 2019.
- Business Quant data shows LLY's Net Equity Issued and Repurchased at -$1.6 billion (Q2 2026), -$2.36 billion (Q1 2026) and -$1.51 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | - |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | -103.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -377.00 Mn |
| Jun 30, 2026 | -1.60 Bn |
| Mar 31, 2026 | -2.36 Bn |
| Dec 31, 2025 | -1.51 Bn |
| Sep 30, 2025 | -708.00 Mn |
| Jun 30, 2025 | -692.00 Mn |
| Mar 31, 2025 | -1.20 Bn |
| Dec 31, 2024 | -2.05 Bn |
| Sep 30, 2024 | -446.10 Mn |
| Mar 31, 2023 | -750.00 Mn |
| Mar 31, 2022 | -1.50 Bn |
| Dec 31, 2021 | -750.00 Mn |
| Jun 30, 2021 | -500.00 Mn |
| Mar 31, 2020 | -500.00 Mn |
| Dec 31, 2019 | -300.00 Mn |
| Sep 30, 2019 | -600.00 Mn |
| Mar 31, 2019 | -3.50 Bn |
| Dec 31, 2018 | -1.10 Bn |
| Sep 30, 2018 | -1.00 Bn |
| Jun 30, 2018 | -950.70 Mn |
API Access
Eli Lilly Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();